| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 22 |
| 1 | PREDNISOLONE ORAL | 22 |
| 2 | PREDNISOLONE ORAL SOLUTION | 22 |
| 3 | CYCLOPHOSPHAMIDE | 19 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 19 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 19 |
| 6 | FUROSEMIDE | 17 |
| 7 | OMEPRAZOLE MAGNESIUM | 13 |
| 8 | METHOTREXATE | 12 |
| 9 | METHOTREXATE SODIUM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-ARGININE | 2 | 0.0056 |
| 1 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 2 | METHYLPHENIDATE HCL | 2 | 0.0016 |
| 3 | GEMTUZUMAB OZOGAMICIN | 5 | 0.0014 |
| 4 | PENICILLAMINE | 1 | 0.0011 |
| 5 | ILOPROST | 1 | 0.0011 |
| 6 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 7 | ARSENIC TRIOXIDE | 2 | 0.0009 |
| 8 | FLECAINIDE ACETATE | 4 | 0.0007 |
| 9 | PRASTERONE | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 46 |
| 1 | Alkylating Drug [EPC] | 23 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 3 | Proton Pump Inhibitor [EPC] | 18 |
| 4 | Loop Diuretic [EPC] | 17 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 7 | Vitamin C [EPC] | 11 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 10 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 5 | 0.0014 |
| 1 | Prostacycline [EPC] | 1 | 0.0011 |
| 2 | Calcitonin [EPC] | 1 | 0.0003 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 4 | Sulfone [EPC] | 2 | 0.0002 |
| 5 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 23 | 0.0001 |
| 8 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 9 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |